Immucothel

Immunocyanine, the active ingredient in Immucothel, is a biologically derived compound presented as a sterile injectable solution for intradermal and subcutaneous use. It is being explored for potential therapeutic applications in immune modulation and related clinical research.

GNH USA supplies Immucothel as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with distribution originating from the European Union market. The company adheres to stringent quality standards and regulatory requirements to ensure product integrity across global supply chains.

Immucothel (Immunocyanine) is currently under investigation for its role in immune system modulation.

- Clinical research: Utilized in studies assessing immune modulation mechanisms. - Pre‑clinical trials: Applied in animal models to investigate immunological effects. - Exploratory therapy: Investigated as an adjunct in experimental protocols for autoimmune conditions.

Adverse reaction information for Immucothel is limited, and reported events are based on early clinical observations.

Common Side Effects: - Injection site pain: Mild discomfort at the injection site. - Redness: Localized erythema around the administration area. - Low‑grade fever: Transient temperature elevation.

Serious or Rare Side Effects: - Anaphylactic reaction: Severe allergic response requiring immediate medical attention. - Severe hypersensitivity: Widespread rash, swelling, or respiratory difficulty. - Autoimmune flare: Exacerbation of underlying autoimmune disease.

When considering Immucothel, several precautionary measures should be observed to ensure safe handling and patient safety.

- Assess patient history: Review prior allergic reactions to biologics. - Monitor immune parameters: Observe for unexpected immune activation. - Pregnancy and lactation: Use only if benefit outweighs risk. - Concurrent immunosuppressants: Evaluate potential additive effects. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions with Immucothel have not been comprehensively characterized.

Major Interactions (Avoid): - Live vaccines: Co‑administration may increase risk of infection. - Strong immunosuppressants: May blunt intended immune modulation. - Cytokine‑targeting agents: Potential for synergistic immune effects.

Moderate Interactions (Monitor Closely): - Anticoagulants: Monitor for bleeding if immune activation alters platelet function. - Hormonal therapies: Observe for altered metabolism. - Herbal immunomodulators: Assess for additive immune activity.